Guillain-Barré Syndrome (GBS) is a rare neurological disorder that can cause sudden weakness and tingling in your extremities. Caused by an immune system malfunction, GBS often follows a viral or bacterial infection. This condition can affect individuals of all ages, but its prevalence tends to be higher among adults between 50 and 70 years old.

For years, muscular dystrophy (MD) has presented a daunting obstacle to patients and families worldwide. However, recent advances in research offer a symbol of hope for the future. Scientists are tirelessly working on revolutionary treatments that aim to not only alleviate symptoms but also to slow down the progression of this debilitating disease.

MRI Mind scan developed utilizing a Gradient-echo stage sequence exhibiting an iron deposit in the white make a difference lesion (inside of green box in the middle of the image; enhanced and marked by red arrow top rated-still left corner)[239] Since disease progression is the result of degeneration of neurons, the roles of proteins displaying lac